Attached files
| file | filename |
|---|---|
| 8-K - 8-K - LUMOS PHARMA, INC. | nlnk-20140108x8k.htm |
| EX-10.2 - 2014 SALARIES, BONUS TARGETS AND EQUITY AWARDS - LUMOS PHARMA, INC. | nlnk-20140108x8kxex102.htm |
Exhibit 10.1
2013 Bonus Awards | ||||||
Name and Title | Bonus Target* | Goal Percentage Achieved | Bonus Target Achieved* | 2013 Salary | Total Cash Bonus Awarded | Restricted Stock Unit Awards |
Charles J. Link, Jr., M.D. | 55% | 100% | 55% | $540,800 | $297,440 | 12,500 |
Chairman of the Board and Chief Executive and Scientific Officer | ||||||
Nicholas N. Vahanian, M.D. | 45% | 100% | 45% | $420,000 | $189,000 | 9,500 |
President and Chief Medical Officer | ||||||
Gordon H. Link, Jr. | 35% | 85% | 30% | $286,600 | $85,264 | |
Chief Financial Officer | ||||||
W. Jay Ramsey, M.D., Ph.D. | 30% | 100% | 30% | $283,800 | $85,140 | |
Quality Assurance Officer | ||||||
*Bonus Targets listed as percentage of 2013 Base Salary | ||||||